|
6VFQ
Crystal structure of monomeric human protocadherin 10 EC1-EC4
Deposited 2020-01-06
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Other combination
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
18–455(438 aa)
|
Not recorded
|
CA CALCIUM ION × 9
MAN alpha-D-mannopyranose × 2
ACT ACETATE ION × 1
EDO 1,2-ETHANEDIOL × 4
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 4.6;296 K;14% PEG 400 (v/v), 0.1M sodium acetate pH 4.6, 0.1M CaCl2, with 30% ethylene glycol (v/v) added as cryoprotectant
|
Resolution 2.30 Å
R-free 0.237
|
|
6VFW
Crystal structure of human delta protocadherin 10 EC1-EC4
Deposited 2020-01-06
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Other combination
Homooligomer;Protein × 2
PDB declaration: dimeric
|
Chain A
18–455(438 aa)
Chain C
18–455(438 aa)
|
Not recorded
|
CA CALCIUM ION × 18
MAN alpha-D-mannopyranose × 4
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 8.5;296 K;12% (w/v) PEG 8000, 20% (v/v) ethylene glycol, 0.1M Tris-bicine buffer pH8.5, 10% 0.02 M D-glucose, 0.02 M D-mannose, 0.02 M D-galactose, 0.02 M L-fucose, 0.02 M D-xylose, 0.02 M N-acetyl-D-glucosamine with no further cryoprotection
|
Resolution 3.60 Å
R-free 0.295
|
|
6VFW
Crystal structure of human delta protocadherin 10 EC1-EC4
Deposited 2020-01-06
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Other combination
Homooligomer;Protein × 2
PDB declaration: dimeric
|
Chain B
18–455(438 aa)
Chain D
18–455(438 aa)
|
Not recorded
|
CA CALCIUM ION × 18
MAN alpha-D-mannopyranose × 4
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 8.5;296 K;12% (w/v) PEG 8000, 20% (v/v) ethylene glycol, 0.1M Tris-bicine buffer pH8.5, 10% 0.02 M D-glucose, 0.02 M D-mannose, 0.02 M D-galactose, 0.02 M L-fucose, 0.02 M D-xylose, 0.02 M N-acetyl-D-glucosamine with no further cryoprotection
|
Resolution 3.60 Å
R-free 0.295
|
|
6VFW
Crystal structure of human delta protocadherin 10 EC1-EC4
Deposited 2020-01-06
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Other combination
Homooligomer;Protein × 2
PDB declaration: dimeric
|
Chain E
18–455(438 aa)
|
Not recorded
|
CA CALCIUM ION × 18
MAN alpha-D-mannopyranose × 4
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 8.5;296 K;12% (w/v) PEG 8000, 20% (v/v) ethylene glycol, 0.1M Tris-bicine buffer pH8.5, 10% 0.02 M D-glucose, 0.02 M D-mannose, 0.02 M D-galactose, 0.02 M L-fucose, 0.02 M D-xylose, 0.02 M N-acetyl-D-glucosamine with no further cryoprotection
|
Resolution 3.60 Å
R-free 0.295
|
|
9DQV
Structure of western equine encephalitis virus CBA87 VLP in complex with human PCDH10 EC1
Deposited 2024-09-24
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 16
PDB declaration: 16-meric
|
Chain M
19–121(103 aa)
Chain N
19–121(103 aa)
Chain O
19–121(103 aa)
Chain P
19–121(103 aa)
|
Not recorded
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 16
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.30 Å
|
|
9E96
WEEV CBA87 VLP in complex with human PCDH10-EC1
Deposited 2024-11-07
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 16
PDB declaration: 16-meric
|
Chain H
19–122(104 aa)
Chain L
19–122(104 aa)
Chain P
19–122(104 aa)
Chain Q
19–122(104 aa)
|
Not recorded
|
No recorded non-water small molecule
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.4
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 4.05 Å
|
|
9L1N
Structure of Western equine encephalitis virus 71V1658 strain VLP in complex with human PCDH10 EC1
Deposited 2024-12-15
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 13
PDB declaration: 13-meric
|
Chain M
19–113(95 aa)
|
Not recorded
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 8
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 8
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.30 Å
|
|
9L41
Structure of WEEV strain 71V1658 virus-like particles (VLPs) in complex with human PCDH10 extracellular cadherin repeats 1-2 (EC1-EC2)(3-fold region)
Deposited 2024-12-19
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 9
PDB declaration: nonameric
|
Chain R
19–114(96 aa)
Chain S
19–114(96 aa)
Chain T
19–114(96 aa)
|
Not recorded
|
No recorded non-water small molecule
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.4
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 2.99 Å
|